Evidence map›Paper›PMID 37958707›Full record

ReviewInternational journal of molecular sciences2023

Silver, Its Salts and Application in Medicine and Pharmacy.

Dominik Żyro, Joanna Sikora, Małgorzata Iwona Szynkowska-Jóźwik, Justyn Ochocki

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Research Progress in Medical Biomaterials for Bone Infections.Journal of functional biomaterials · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Clinical translation and landscape of silver nanoparticles.Drug delivery and translational research · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Mechanisms of Triton X-100 reducing the AgWorld journal of microbiology & biotechnology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dominik ŻyroDepartment of Bioinorganic Chemistry, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0003-1594-8366
Joanna SikoraDepartment of Bioinorganic Chemistry, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-7044-9696
Małgorzata Iwona Szynkowska-JóźwikFaculty of Chemistry, Institute of General and Ecological Chemistry, Lodz University of Technology, Zeromskiego 116, 90-543 Lodz, Poland.ORCID 0000-0003-1959-3849
Justyn OchockiMedical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.ORCID 0000-0001-8959-4711
Medical University of Lodz · PLLodz University of Technology · PL

Funding

Medical University of Lodz 503/3-016-02/503-31-001
6 · The paper itself

Abstract

The healing properties of silver have been used since ancient times. The main aim of the study was to collect and review the literature on the clinical potential of silver, its salts and complex compounds. The second goal was to present an outline of the historical use of silver in medicine and pharmacy, taking into account the possibility of producing pharmaceutical drug forms on the premises of pharmacies. In the context of the growing resistance of microorganisms to available, widely used antibiotics, silver plays a key role. There is only one known case of bacterial resistance to silver-the

Indexed as

Anti-Infective AgentsPharmaciesPharmacyAnti-Bacterial AgentsPharmaceutical PreparationsSaltsSilverSilver CompoundsAnti-Bacterial AgentsAnti-Infective AgentsPharmaceutical PreparationsSaltsSilverSilver Compoundsantimicrobial activitychemical stabilitycytotoxicitysilver (I)silver (I) complexessilver (I) salts

Identifiers

PMID37958707
PMCPMC10650883
OpenAlexW4388159528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.